You are here

Molecular Imaging

You are here

Molecular Imaging

 

Recent Headlines

Visual rating of dementia PET scans stumps some readers

Amyloid imaging can tell Alzheimer’s disease (AD) and frontotemporal dementia (FTD) apart because FTD typically does not show the same pattern of amyloid, right? Not so fast, say brain researchers.

The rising tide of Alzheimer’s

As the baby boomers shift into retirement, it’s always been known that the prevalence of age-related conditions such as Alzheimer’s disease was going to increase. Numbers released last month from the Alzheimer’s Association provided the latest estimate of just how severe the impact will be.

SNMMI: Dual tracers could deliver effectiveness, convenience + savings

A hybrid imaging technique which combines PET/CT with two molecular imaging agents targeting different markers of disease has been shown to aid in the detection of tumors in complex cases of bone cancer, according to research presented at the annual meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI).

SNMMI 2012 Image of the Year award unveiled

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has selected its 2012 Image of the Year. This years winner illustrates the effectiveness of Bi-213-DOTATOC for the peptide receptor alpha-therapy of gastroenteropancreatic neuroendocrine tumors that do not respond to beta therapy.

SNMMI: PET sheds light on pre-symptomatic Alzheimers

MIAMIMolecular imaging detects the pathology that leads to Alzheimers disease years before the development of symptoms, which could allow physicians to detect signs of the disease in healthy patients, according to studies presented June 11 at the annual meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI).

SNMMI: MI shows promise in differentiating dementias

MIAMI -The routine clinical diagnostic accuracy for dementia hovers in the 50 to 80 percent range, yet the capability to differentiate Alzheimers disease, dementia with Lewy bodies and frontotemporal lobe dementia will be critical as therapeutic treatment strategies are identified. PET imaging with novel radiopharmaceuticals could provide physicians the key they need to unlock the mysteries of various dementias, Kirk A. Frey, MD, PhD, told the audience during the June 10 plenary session at the annual meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI).